Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.
about
Incidence and risk of hypertension associated with cabozantinib in cancer patients: a systematic review and meta-analysis.Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients.Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.Cardiovascular safety and hemodynamic considerations in oncology drug development - webinar highlights October 10th 2012.The adverse effects of sorafenib in patients with advanced cancers.Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma.Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma.Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma.Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.Perioperative Considerations in Metastatic Renal Cell Carcinoma.
P2860
Q30250303-3FB20379-AAB2-42A1-845B-42B51379DB44Q33778275-CBCC0706-7A4E-46CF-8583-43B443AFD453Q35932363-6FA7E2C6-F322-41F7-8333-2D01B65B53E2Q38104812-C0462079-C3DB-4911-B275-791083004469Q38286308-9F2E8F56-9EA7-468E-B978-41E05A9E240BQ38754136-4E8DEB04-02BD-4FED-A10C-30A4E4071BAAQ41573990-5F5E67BC-5762-4195-BC91-1393385F0C3FQ44833504-F46E5DF0-6BB9-4EB1-89CE-E7830CA07FAFQ45329617-D4B91311-DF7F-4815-9362-367E757E019CQ52571238-1F7399EA-3625-42AE-8D85-783891A4A902Q52816951-3786B0F0-3298-45A0-9079-607EA9D261C9
P2860
Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hypertension management in pat ...... d with anti-angiogenic agents.
@ast
Hypertension management in pat ...... d with anti-angiogenic agents.
@en
type
label
Hypertension management in pat ...... d with anti-angiogenic agents.
@ast
Hypertension management in pat ...... d with anti-angiogenic agents.
@en
prefLabel
Hypertension management in pat ...... d with anti-angiogenic agents.
@ast
Hypertension management in pat ...... d with anti-angiogenic agents.
@en
P2093
P2860
P356
P1433
P1476
Hypertension management in pat ...... d with anti-angiogenic agents.
@en
P2093
C Kollmannsberger
E L Schiffrin
F Patenaude
G Bjarnason
P Larochelle
R D Feldman
P2860
P304
P356
10.3747/CO.19.972
P577
2012-08-01T00:00:00Z